A new teat seal which is proven to dramatically reduce mastitis in the 100 days post calving could deliver returns on investment of up to 300%.
Boviseal boasts a significant return on investment and is a great opportunity for dairy farmers to re-evaluate their dry cow therapy and mastitis control, says manufacturer Bimeda’s head of technical services, Padraig Hyland.
“The UK launch of Boviseal is a great opportunity for farmers to reassess the damage and cost of mastitis and the potential savings of the correct use of a seal. Boviseal is the highest-selling teat seal in the Republic of Ireland, with two-thirds of the Irish dairy cows sealed annually,” he says.
When it comes to dry cow therapy, Mr Hyland says the evidence showing the value of combined sealing and antibiotic therapy is all too clear. He points to a case study at Waterwheel Farm in Donegal, Ireland, which delivered a 300% return on investment. “Combined therapy might sound costly, but two years of monitoring on this farm saw annual mastitis cases fall dramatically, from 26 for every 100 cows to nine for every 100.
“DEFRA figures indicate mastitis is the most costly disease problem faced by UK dairy farmers, with a typical case costing £175. When you compare that with the cost of treatment for the herd there’s no real counter argument in my opinion,” he says.
Boviseal contains 65% of bismuth sub-nitrate. The effectiveness of teat sealing is proven, but correct administration is key, says Mr Hyland. “Teats need to be thoroughly cleaned and disinfected before sealing. Then the top of the teat below the udder is pinched and the seal is infused into the teat canal. It’s important to note that the conventional practice of massaging into the udder after infusion in not employed.”
For more information go to www.boviseal.co.uk
Find out more about dry cow therapy practices